Atlas Trials

Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults

Clinical trial NCT01879163 · COMPLETED

Trial details

NCT number
NCT01879163
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tuberculosis (TB)
Start date
2013-07-01
Primary completion
2014-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.